Both nicotinamide analogs attenuated α-synuclein-induced SH-SY5Y viability loss [128], suggesting that Sirt2 inhibitors with dual binding modes retain translational potential in neurodegenerative diseases [128]. Here, SIRT2 is linked to neurodegenerative disease.